Loading…
Product type
Canagliflozin is an active pharmaceutical ingredient (API) used primarily in the treatment of type 2 diabetes. It belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by preventing the reabsorption of glucose in the kidneys, thereby promoting its excretion through urine. This mechanism helps lower blood sugar levels in patients with diabetes.
| Chemical formula | C24H25ClO8S |
| Molecular weight | 444.97 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder or crystalline form |
| Solubility | Soluble in organic solvents, slightly soluble in water |
When selecting Canagliflozin, buyers should consider the required purity levels and the specific formulation needed for their applications. It is important to specify the desired quantity and any relevant certifications or compliance standards required for pharmaceutical use. Additionally, buyers should inquire about the availability of documentation such as certificates of analysis and stability data.
Get quotes for Canagliflozin
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Canagliflozin is used to treat type 2 diabetes by lowering blood sugar levels.
It works by inhibiting the SGLT2 protein in the kidneys, reducing glucose reabsorption.
It is typically available in powder or crystalline form.
Purity levels are typically ≥ 98%.
It is slightly soluble in water but soluble in organic solvents.
It is used in pharmaceutical manufacturing, diabetes treatment, and research.
Specify purity, quantity, and any necessary certifications or compliance standards.